51632-31-6 Usage
Classification
Nonsteroidal anti-inflammatory drug (NSAID) This categorizes the compound as a medication used to relieve pain and reduce inflammation.
Mechanism of action
Inhibition of prostaglandin production The compound works by inhibiting the production of prostaglandins, which are responsible for causing pain and inflammation in the body.
Administration route
Oral The compound is typically taken by mouth for its therapeutic effects.
Medical uses
Treatment of conditions like arthritis and menstrual pain The compound is used to alleviate pain and inflammation associated with these conditions.
Potential side effects
Stomach irritation, dizziness, and headache These are some of the possible adverse effects that may occur while using the compound.
Importance of supervision
Use under the guidance of a healthcare professional To minimize the risk of adverse effects, it is crucial to use this compound under the supervision of a medical professional.
Check Digit Verification of cas no
The CAS Registry Mumber 51632-31-6 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 5,1,6,3 and 2 respectively; the second part has 2 digits, 3 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 51632-31:
(7*5)+(6*1)+(5*6)+(4*3)+(3*2)+(2*3)+(1*1)=96
96 % 10 = 6
So 51632-31-6 is a valid CAS Registry Number.
InChI:InChI=1/C12H16O3/c1-8(2)11(12(13)14)9-4-6-10(15-3)7-5-9/h4-8,11H,1-3H3,(H,13,14)
51632-31-6Relevant articles and documents
Preparation of aryl alkyl ketenes
Staudaher, Nicholas D.,Lovelace, Joseph,Johnson, Michael P.,Louie, Janis
, p. 1 - 15 (2017/06/02)
-
Highly enantioselective direct alkylation of arylacetic acids with chiral lithium amides as traceless auxiliaries
Stivala, Craig E.,Zakarian, Armen
supporting information; experimental part, p. 11936 - 11939 (2011/09/19)
A direct, highly enantioselective alkylation of arylacetic acids via enediolates using a readily available chiral lithium amide as a stereodirecting reagent has been developed. This approach circumvents the traditional attachment and removal of chiral auxiliaries used currently for this type of transformation. The protocol is operationally simple, and the chiral reagent is readily recoverable.
Optisch aktive α-Arylcarbonsaeuren durch kinetische Enantiomerentrennung: Pyrethroidsaeuren
Gaertner, Holger,Salz, Ulrich,Ruechardt, Christoph
, p. 166 - 167 (2007/10/02)
-